Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MNG Laboratories

MNG Laboratories
2001 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of molecular and neurochemical genetic testing for inherited genetic disorders. The company focuses on testing for neurological disorders, such as epilepsy and muscular dystrophy, as well as mitochondrial disorders such as cellular energetics defects affecting children and adults.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
  • 5424 Glenridge Drive North East
  • Atlanta, GA 30342
  • United States

+1 (678) 000-0000

MNG Laboratories Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore MNG Laboratories‘s full profile, request access.

Request full access to PitchBook

MNG Laboratories Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore MNG Laboratories‘s full profile, request access.

Request full access to PitchBook

MNG Laboratories Executive Team (6)

Name Title Board
Seat
Contact
Info
Terry Conrad Chief Executive Officer & President
Ralph Nelson Chief Financial Officer
Steve Nelson Chief Information Officer
Peter Nagy Ph.D Chief Medical Officer

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »